Exome Asset Management »

Legend Biotech 2 Adr Rep Ord shares owned by Exome Asset Management

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.3M 38k 60.17

More positions owned by Exome Asset Management

Dr Reddys Labs Adr (RDY)
Eli Lilly & Co. (LLY)
ImmunoGen
Cigna Corp (CI)
Celldex Therapeutics Com New (CLDX)
Tg Therapeutics (TGTX)
Rhythm Pharmaceuticals (RYTM)
Alpine Immune Sciences (ALPN)
Dex (DXCM)
Madrigal Pharmaceuticals (MDGL)
Cytokinetics Com New (CYTK)
Inhibrx (INBX)
Structure Therapeutics Sponsored Ads (GPCR)
Rocket Pharmaceuticals (RCKT)
Bridgebio Pharma (BBIO)

View all positions for Exome Asset Management

Top funds holding Legend Biotech 2 Adr Rep Ord

T. Rowe Price Associates
RA Capital Management
Hillhouse Capital Advisors
Wellington Management Company
Massachusetts Financial Services
Paradigm Biocapital Advisors
Henderson Group
Westfield Capital Management Company
Holocene Advisors
Federated Investors
Alliancebernstein
TimesSquare Capital Management
Arrowpoint Asset Management
Matthews International Capital Management
Avidity Partners Management

View all funds holding Legend Biotech 2 Adr Rep Ord